PReS-FINAL-2205: Vascular risk assesment and MMP-3 gene in FMF

B. Sozeri,S. Mir,K. Ozdemir,A. Berdeli

DOI: https://doi.org/10.1186/1546-0096-11-S2-P195

2013-12-05

Abstract:

What problem does this paper attempt to address?

Assessment of epicardial adipose tissue thickness and the mean platelet volume in children with familial Mediterranean fever

Ünal Uluca,Fikri Demir,Aydın Ece,Velat Şen,Ali Güneş,Fesih Aktar,İlhan Tan,Duran Karabel,Ümitcan Yazgan,Muhammed Nurullah Sabaz

DOI: https://doi.org/10.1186/s13052-015-0120-z

IF: 3.288

2015-02-22

Italian Journal of Pediatrics

Abstract:BackgroundFamilial Mediterranean fever (FMF) is an inflammatory disease, which is suggested to be associated with increased risk of atherosclerosis. Epicardial adipose tissue (EAT) thickness and the mean platelet volume (MPV) are parameters used in prediction of atherosclerotic risk in various conditions. These parameters were evaluated in children with FMF and compared with healthy controls.MethodsForty-five patients with FMF and 54 age- and gender-matched healthy controls were assessed. Duration of symptoms, age at diagnosis, duration of delay in diagnosis, frequency and duration of FMF attacks, disease severity scores, response to colchicine therapy, MEditerraneanFeVer (MEFV) gene mutations, and MPV values were recorded. EAT thicknesses were measured by echocardiography.ResultsEpicardial adipose tissue thicknesses of the children with FMF were found to be significantly greater than that of controls (5.1 ± 1.4 vs. 4.5 ± 0.9 mm, p = 0.036). FMF patients had significantly higher MPV values compared with the controls (7.8 ± 1.1 vs. 7.3 ± 1.4 fl, p = 0.044). Age at diagnosis, duration of delay in diagnosis, and MPV values were found to be correlated with EAT thickness in the patient group (r = 0.49, p = 0.001 for the former parameters and r = 0.32, p = 0.04 for MPV).ConclusionEpicardial adipose tissue thickness and MPV values seem to be increased in children with FMF. These findings may indicate an increased risk of atherosclerosis in FMF patients.

pediatrics
α9β1 integrin & its ligands as new potential biomarkers in FMF

Pınar Ellergezen,Belkıs Nihan Coşkun,Zeynep Yılmaz Bozkurt,Gülce Sevdar Çeçen,Harun Ağca,Yavuz Pehlivan,Hüseyin Ediz Dalkılıç,Sinan Çavun,Yusuf Berkcan Yanar

DOI: https://doi.org/10.25259/ijmr_985_23

Abstract:Background & objectives Familial Mediterranean Fever (FMF) manifests as a hereditary condition characterized by repeated bouts of fever, abdominal, chest, and joint discomfort, and swelling. Colchicine is the most common form of treatment, but it does not eliminate the disease. The underlying causes of the inflammatory mechanism are still not fully known. Methods A total of 20 healthy controls, 16 individuals with FMF in the attack period, and 14 in the remission period participated in the study. ITGA9, ITGB1, OPN, TNC, VEGF, VCAM-1, TGM2, TSP-1, Emilin-1, and vWF levels were measured by ELISA by obtaining serum from blood samples of individuals. In addition, gene expressions of α9β1 (ITGA9, ITGB1) and its best known ligands (TNC, SPP1) were analyzed by quantitative real-time PCR (qPCR). Results The findings of this study showed that serum levels of α9β1 and its ligands were higher in individuals with FMF in the attack period than in the healthy controls and the FMF group in the remission period (P<0.05). The marker levels of the healthy group were also higher than those in the remission period (p<0.05). In addition, when the gene expressions were compared between the healthy controls and FMF group, no significant difference was found for ITGA9, ITGB1, TNC, and SPP1 genes. Interpretation & conclusions The function of α9β1 and its ligands in FMF disease was investigated for the first time in this study as per our knowledge. Serum levels of these biomarkers may help identify potential new targets for FMF disease diagnosis and treatment approaches.
Exploring S100A8/A9, neopterin, and MMP3 in familial Mediterranean fever

Ozgur C Kilinc,Yonca S Akdeniz,Zuleyha Taskin,Mehmet Karabulut,Arif Kaya,Ibrahim Murat Bolayırlı,Gunay Can,Serdal Ugurlu

DOI: https://doi.org/10.1093/cei/uxae049

2024-09-16

Abstract:Familial Mediterranean fever (FMF) is characterized by inflammatory attacks due to overactivation of pyrin inflammasome. This study aimed to investigate the reliability of S100A8/A9, neopterin, and matrix metalloproteinase 3 (MMP3) at monitoring subclinical inflammation and disease activity, and at differentiating FMF attacks from appendicitis, the most common misdiagnosis among FMF patients. Blood samples (n = 75), comprising from FMF patients during an attack (n = 20), the same FMF patients during the attack-free period (n = 14), patients with appendicitis (n = 24), and healthy volunteers (n = 17) were obtained. Duplicate determinations of S100A8/A9, neopterin, and MMP-3 levels were conducted using the enzyme-linked immunosorbent assay (ELISA). FMF patients with and without attack and patients with appendicitis had significantly elevated S100A8/A9 levels compared to healthy volunteers (P-values: < 0.001, 0.036, 0.002, respectively). Patients with appendicitis and FMF patients with and without attack had significantly increased serum neopterin levels compared to healthy volunteers (P-value: < 0.001). MMP3 levels were significantly higher among patients with appendicitis and FMF patients during attack compared to healthy controls (P-values: < 0.001, 0.001). Serum levels of S100A8/A9, neopterin, and MMP3 were increased significantly during attacks compared to attack-free periods among FMF patients (P-values: 0.03, 0.047, 0.007). S100A8/A9 emerges as a valuable marker for monitoring disease activity. Neopterin and S100A8/A9 might help physicians to monitor subclinical inflammation during the attack-free periods of FMF patients. MMP3 might aid in diagnosing FMF attacks when distinguishing between attack and attack-free periods is challenging.
Clinical Implications of Three-Vessel Fractional Flow Reserve Measurement in Patients with Coronary Artery Disease

Joo Myung Lee,Bon-Kwon Koo,Eun-Seok Shin,Chang-Wook Nam,Joon-Hyung Doh,Doyeon Hwang,Jonghanne Park,Xinyang Hu,Jianan Wang,Ahn Chul,Fei Ye,Shaoliang Chen,Junqing Yang,Jiyan Chen,Nobuhiro Tanaka,Hiroyoshi Yokoi,Hitoshi Matsuo,Hiroaki Takashima,Yasutsugu Shiono,Takashi Akasaka

DOI: https://doi.org/10.1093/eurheartj/ehx458

IF: 39.3

2017-01-01

European Heart Journal

Abstract:AimsThere are limited data on the clinical implications of total physiologic atherosclerotic burden assessed by invasive physiologic studies in patients with coronary artery disease. We investigated the prognostic implications of total physiologic atherosclerotic burden assessed by total sum of fractional flow reserve (FFR) in three vessels (3V-FFR).Methods and resultsA total of 1136 patients underwent FFR measurement in three vessels (3V FFR-FRIENDS study, NCT01621438). The patients were classified into high and low 3V-FFR groups according to the median value of 3V-FFR (2.72). The primary endpoint was major adverse cardiac events (MACE, a composite of cardiac death, myocardial infarction and ischaemia-driven revascularization) at 2 years. Mean angiographic percent diameter stenosis and FFR were 43.7 ± 19.3% and 0.90 ± 0.08, respectively. There was a negative correlation between 3V-FFR and estimated 2-year MACE rate (P < 0.001). The patients in low 3V-FFR group showed a higher risk of 2-year MACE than those in the high 3V-FFR group [(7.1% vs. 3.8%, hazard ratio (HR) 2.205, 95% confidence interval (CI) 1.201-4.048, P = 0.011]. The higher 2-year MACE rate was mainly driven by the higher rate of ischaemia-driven revascularization in the low 3V-FFR group (6.2% vs. 2.7%, HR 2.568, 95% CI 1.283-5.140, P = 0.008). In a multivariable adjusted model, low 3V-FFR was an independent predictor of MACE (HR 2.031, 95% CI 1.078-3.830, P = 0.029).ConclusionPatients with high total physiologic atherosclerotic burden assessed by 3V-FFR showed higher risk of 2-year clinical events than those with low total physiologic atherosclerotic burden. The difference was mainly driven by ischaemia-driven revascularization for both functionally significant and insignificant lesions at baseline. Three-vessel FFR might be used as a prognostic indicator in patients with coronary artery disease.Clinical trial registration3V FFR-FRIENDS study (https://clinicaltrials.gov/ct2/show/NCT01621438, NCT01621438).
Pan-Immune-Inflammation Value Could Be a New Marker to Predict Amyloidosis and Disease Severity in Familial Mediterranean Fever

Tuğba Ocak,Ahmet Görünen,Belkıs Nihan Coşkun,Burcu Yağız,Sebnem Ozemri Sağ,Gökhan Ocakoğlu,Ediz Dalkılıç,Yavuz Pehlivan

DOI: https://doi.org/10.3390/diagnostics14060634

IF: 3.6

2024-03-17

Diagnostics

Abstract:Familial Mediterranean fever (FMF) is characterized by recurrent episodes of fever and serositis. Blood-based biomarkers determined in FMF patients during attack-free periods could be used to predict the risk of amyloidosis and the severity of the disease. The recently defined pan-immune-inflammation value (PIV) comprises four distinct subsets of blood cells and serves as an easily accessible and cost-effective marker. The objective of this study was to assess the role of PIV in predicting amyloidosis and moderate-to-severe disease. Clinical characteristics and laboratory values during the attack-free period were retrospectively analyzed in 321 patients over 18 years of age diagnosed with familial Mediterranean fever (FMF). In our tertiary adult rheumatology outpatient clinic, disease severity and laboratory markers were evaluated during the first attack-free interval. At baseline, patients with amyloidosis were excluded. Patients were categorized based on the presence of amyloidosis and the severity of the disease. When focusing on amyloidosis in receiver operating characteristic (ROC) analysis, optimal cut-off values for pan-immune-inflammation value (PIV), neutrophil-to-lymphocyte ratio (NLR), and platelet-to-lymphocyte ratio were determined as ≥518.1, ≥2.3, and ≥127.2, respectively. In multivariate analysis, PIV, C-reactive protein (CRP), and the presence of the M694V homozygous mutation emerged as independent risk factors for both amyloidosis and moderate-to-severe disease. Additionally, NLR was identified as an independent risk factor for amyloidosis, while red blood cell distribution width was associated with moderate-to-severe disease. In patients with FMF, especially in the presence of the M694V homozygous mutation, CRP and PIV may be useful in predicting both amyloidosis and moderate-to-severe disease.

medicine, general & internal
Association of MMP9 with adverse features of plaque progression and residual inflammatory risk in patients with chronic coronary syndrome (CCS)

Chiara Caselli,Nicoletta Di Giorgi,Rosetta Ragusa,Valentina Lorenzoni,Jeff Smit,Mohammed El Mahdiui,Ronny R Buechel,Anna Teresinska,Maria N Pizzi,Albert Roque,Rosa Poddighe,Juhani Knuuti,Moritz Schütte,Oberdan Parodi,Gualtiero Pelosi,Arthur Scholte,Silvia Rocchiccioli,Danilo Neglia,SMARTool Investigators

DOI: https://doi.org/10.1016/j.vph.2022.107098

Abstract:Background and aims: MMP-9 is a predictor of atherosclerotic plaque instability and adverse cardiovascular events, but longitudinal data on the association between MMP9 and coronary disease progression are lacking. This study is aimed at investigating whether MMP9 is associated with atherosclerotic plaque progression and the related molecular basis in stable patients with chronic coronary syndrome (CCS). Methods: MMP9 serum levels were measured in 157 CCS patients (58 ± 8 years of age; 66% male) undergoing coronary computed tomography angiography at baseline and after a follow up period of 6.5 ± 1.1 years to assess progression of Total, Fibrous, Fibro-fatty, Necrotic Core, and Dense Calcium plaque volumes (PV). Gene expression analysis was evaluated in whole blood using a transcriptomic approach by RNA-seq. Results: At multivariate analysis, serum MMP9 was associated with annual change of Total and Necrotic Core PV (Coefficient 3.205, SE 1.321, P = 0.017; 1.449, SE 0.690, P = 0.038, respectively), while MMP9 gene expression with Necrotic Core PV (Coefficient 70.559, SE 32.629, P = 0.034), independently from traditional cardiovascular risk factors, medications, and presence of obstructive CAD. After transcriptomic analysis, MMP9 expression was linked to expression of genes involved in the innate immunity. Conclusions: Among CCS patients, MMP9 is an independent predictive marker of progression of adverse coronary plaques, possibly reflecting the activity of inflammatory pathways conditioning adverse plaque phenotypes. Thus, blood MMP9 might be used for the identification of patients with residual risk even with optimal management of classical cardiovascular risk factors who may derive the greatest benefit from targeted anti-inflammatory drugs.
Risk for cancer development in familial Mediterranean fever and associated predisposing factors: an ambidirectional cohort study from the international AIDA Network registries

Antonio Vitale,Valeria Caggiano,Abdurrahman Tufan,Gaafar Ragab,Ezgi Deniz Batu,Piero Portincasa,Emma Aragona,Jurgen Sota,Giovanni Conti,Amato De Paulis,Donato Rigante,Alma Nunzia Olivieri,Ali Şahin,Francesco La Torre,Giuseppe Lopalco,Marco Cattalini,Maria Cristina Maggio,Antonella Insalaco,Petros P Sfikakis,Elena Verrecchia,Derya Yildirim,Hamit Kucuk,Riza Can Kardas,Ahmed Hatem Laymouna,Mahmoud Ghanema,Moustafa Ali Saad,Seher Sener,Hulya Ercan Emreol,Seza Ozen,Nour Jaber,Mohamad Khalil,Agostino Di Ciaula,Carla Gaggiano,Giuseppe Malizia,Andrea Affronti,Serena Patroniti,Meri Romeo,Jessica Sbalchiero,Francesca Della Casa,Ilaria Mormile,Sara Silvaroli,Maria Francesca Gicchino,Neşe Çabuk Çelik,Maria Tarsia,Anastasios Karamanakos,José Hernández-Rodríguez,Paola Parronchi,Daniela Opris-Belinski,Patrizia Barone,Andreas Recke,Stefania Costi,Paolo Sfriso,Henrique A Mayrink Giardini,Stefano Gentileschi,Ewa Wiesik-Szewczyk,Ibrahim Vasi,Roberta Loconte,Karina Jahnz-Różyk,Eduardo Martín-Nares,Jiram Torres-Ruiz,Alberto Cauli,Alessandro Conforti,Giacomo Emmi,Francesca Li Gobbi,Giovanni Rosario Biasi,Riccardo Terribili,Piero Ruscitti,Emanuela Del Giudice,Samar Tharwat,Antonio Luca Brucato,Benson Ogunjimi,Andrea Hinojosa-Azaola,Alberto Balistreri,Claudia Fabiani,Bruno Frediani,Luca Cantarini

DOI: https://doi.org/10.3389/fimmu.2024.1397890

2024-05-10

Abstract:Objective: Inflammation has been associated with an increased risk for cancer development, while innate immune system activation could counteract the risk for malignancies. Familial Mediterranean fever (FMF) is a severe systemic inflammatory condition and also represents the archetype of innate immunity deregulation. Therefore, the aim of this study is to investigate the risk for cancer development in FMF. Methods: The risk ratio (RR) for malignancies was separately compared between FMF patients and fibromyalgia subjects, Still's disease patients and Behçet's disease patients. Clinical variables associated with cancer development in FMF patients were searched through binary logistic regression. Results: 580 FMF patients and 102 fibromyalgia subjects, 1012 Behçet's disease patients and 497 Still's disease patients were enrolled. The RR for the occurrence of malignant neoplasms was 0.26 (95% Confidence Interval [CI.] 0.10-0.73, p=0.006) in patients with FMF compared to fibromyalgia subjects; the RR for the occurrence of malignant cancer was 0.51 (95% CI. 0.23-1.16, p=0.10) in FMF compared to Still's disease and 0.60 (95% CI. 0.29-1.28, p=0.18) in FMF compared to Behçet's disease. At logistic regression, the risk of occurrence of malignant neoplasms in FMF patients was associated with the age at disease onset (β1 = 0.039, 95% CI. 0.001-0.071, p=0.02), the age at the diagnosis (β1 = 0.048, 95% CI. 0.039-0.085, p=0.006), the age at the enrolment (β1 = 0.05, 95% CI. 0.007-0.068, p=0.01), the number of attacks per year (β1 = 0.011, 95% CI. 0.001- 0.019, p=0.008), the use of biotechnological agents (β1 = 1.77, 95% CI. 0.43-3.19, p=0.009), the use of anti-IL-1 agents (β1 = 2.089, 95% CI. 0.7-3.5, p=0.002). Conclusions: The risk for cancer is reduced in Caucasic FMF patients; however, when malignant neoplasms occur, this is more frequent in FMF cases suffering from a severe disease phenotype and presenting a colchicine-resistant disease.
Identification of a functional missense variant in the matrix metallopeptidase 10 (MMP10) gene in two families with premature myocardial infarction

Viktor Verovenko,Stephanie Tennstedt,Mariana Kleinecke,Thorsten Kessler,Heribert Schunkert,Jeanette Erdmann,Stephan Ensminger,Zouhair Aherrahrou

DOI: https://doi.org/10.1038/s41598-024-62878-3

IF: 4.6

2024-05-30

Scientific Reports

Abstract:A positive family history is a major independent risk factor for atherosclerosis, and genetic variation is an important aspect of cardiovascular disease research. We identified a heterozygous missense variant p.L245P in the MMP10 gene in two families with premature myocardial infarction using whole-exome sequencing. The aim of this study was to investigate the consequences of this variant using in-silico and functional in-vitro assays. Molecular dynamics simulations were used to analyze protein interactions, calculate free binding energy, and measure the volume of the substrate-binding cleft of MMP10-TIMP1 models. The p.L245P variant showed an altered protein surface, different intra- and intermolecular interactions of MMP10-TIMP1, a lower total free binding energy between MMP10-TIMP1, and a volume-minimized substrate-binding cleft of MMP10 compared to the wild-type. For the functional assays, human THP-1 cells were transfected with plasmids containing MMP10 cDNA carrying the p.L245P and wild-type variant and differentiated into macrophages. Macrophage adhesion and migration assays were then conducted, and pro-inflammatory chemokine levels were evaluated. The p.L245P variant led to macrophages that were more adherent, less migratory, and secreted higher levels of the pro-inflammatory chemokines CXCL1 and CXCL8 than wild-type macrophages. Thus, the p.L245P variant in MMP10 may influence the pathogenesis of atherosclerosis in families with premature myocardial infarction by altering protein - protein interactions, macrophage adhesion and migration, and expression of pro-inflammatory chemokines, which may increase plaque rupture. These results could contribute to the development of selective MMP10 inhibitors and reduce the risk of atherosclerosis in families with a history of premature myocardial infarction.

multidisciplinary sciences
(O-12) Modulation Of Mmp Expression And Collagen Deposition In The Tunica Albuginea In Peyronie ́S Disease Induced After Treatment With Mycophenolate Mofetil

F Facio,T Antoniassi,T F Rocha Ruiz,S Taboga,S Jacovaci Colleta,L R Falleiros Junior

DOI: https://doi.org/10.1093/jsxmed/qdae018.009

2024-03-29

The Journal of Sexual Medicine

Abstract:Peyronie's disease (PD) is a progressive fibrotic disorder affecting the tunica albuginea (TA) of the penis. MMF was evaluated previously after experimental induction of PD. We investigate the modulation of metalloprotease (MMP) expression and collagen deposition in the TA in PD induced after treatment with MMF in rats. Rats were divided into: control group; sham (injection of saline solution); only TGFβ injection (7 or 30 days); TGFβ injection and treatment with MMF (7 or 30 days). Samples were collected for histochemical and immunohistochemistry, measurements of collagen fibers and MMP expression were performed in random fields. Statistical analyses were checked for normality using the Kolmogorov-Smirnov test, followed by ANOVA test or Kruskal-Wallis test. Results Collagen type I (COLI) was decreased in 7 and 30 days (43.19% ± 1.22; 38.14%1.23), and collagen type III (COLIII) was increased in both periods in the TGFβ induction (56.81% ± 1.22; 61.86% ± 1.23). COLI/COLIII ratio of MMF treatment (7 days) was enhanced (54.74% ± 2.86; 45.26% ± 2.88). COLI (7 and 30 days) were statistically different, as well as 30 days of MMF treatment decreased COLIII (27.41% ± 3.11). MMP was increased at 7 days after TGFβ induction. However, 30 days after induction, MMP expression decreased (1.67% ± 0.16), whereas, with MMF treatment, increased (2.44% ± 0.22). MMP3 expression was similar in both groups. Within 7 days, MMP was enhanced (4.77% ± 0.37; 4.43% ± 0.43) and decreased in 30 days (3.73% ± 0.38; 3.20% ± 0.33). MMP presented an enhancement at 7 days in TGFβ-induction, with (17.56% ± 0.97) or without (13.41% ± 1.31) MMF treatment. However, with MMF treatment at 7 days, MMP showed increased values, and, at 30 days, MMP no differences were observed. Conclusions Induction with TGFβ promoted an imbalance the COLI/COLIII ratio of the tunica albuginea, and the MMF treatment promoted recovery of collagen status. MMP expression were altered, and MMF promoted the collagen recovery by MMP modulation. Financing No conflict.

urology & nephrology
A Marfan syndrome gene expression phenotype in cultured skin fibroblasts

Zizhen Yao,Jochen C Jaeger,Walter L Ruzzo,Cecile Z Morale,Mary Emond,Uta Francke,Dianna M Milewicz,Stephen M Schwartz,Eileen R Mulvihill

DOI: https://doi.org/10.1186/1471-2164-8-319

IF: 4.547

2007-09-12

BMC Genomics

Abstract:Abstract Background Marfan syndrome (MFS) is a heritable connective tissue disorder caused by mutations in the fibrillin-1 gene. This syndrome constitutes a significant identifiable subtype of aortic aneurysmal disease, accounting for over 5% of ascending and thoracic aortic aneurysms. Results We used spotted membrane DNA macroarrays to identify genes whose altered expression levels may contribute to the phenotype of the disease. Our analysis of 4132 genes identified a subset with significant expression differences between skin fibroblast cultures from unaffected controls versus cultures from affected individuals with known fibrillin-1 mutations. Subsequently, 10 genes were chosen for validation by quantitative RT-PCR. Conclusion Differential expression of many of the validated genes was associated with MFS samples when an additional group of unaffected and MFS affected subjects were analyzed (p-value < 3 × 10 -6 under the null hypothesis that expression levels in cultured fibroblasts are unaffected by MFS status). An unexpected observation was the range of individual gene expression. In unaffected control subjects, expression ranges exceeding 10 fold were seen in many of the genes selected for qRT-PCR validation. The variation in expression in the MFS affected subjects was even greater.

genetics & heredity,biotechnology & applied microbiology
Serum endocan, asymmetric dimethylarginine and lipid profile in children with familial Mediterranean fever

Rania S. El Zayat,Fahima M. Hassan,Noran T. Aboelkhair,Walaa F. Abdelhakeem,Ahmed S. Abo Hola

DOI: https://doi.org/10.1038/s41390-024-03093-8

IF: 3.953

2024-02-24

Pediatric Research

Abstract:Familial Mediterranean fever (FMF) is a chronic inflammatory disease, and it is thought that subclinical inflammation persists even when there are no attacks, eventually causing endothelial dysfunction (ED) and atherosclerosis. Limited data are available about serum endocan, asymmetric dimethylarginine (ADMA) and lipid profile in children with FMF, so we aimed to evaluate these markers in children with FMF during the attack-free period.

pediatrics
EMMPRIN Tissue and Plasma Levels in Marfan Syndrome-Related Thoracic Aortic Aneurysms

Kyle C. Alexander,Carlton W. Anderson,Chris B. Agala,Panagiotis Tasoudis,Elizabeth N. Collins,Yiwen Ding,John W. Blackwell,Danielle E. Willcox,Behzad S. Farivar,Melina R. Kibbe,John S. Ikonomidis,Adam W. Akerman

DOI: https://doi.org/10.3390/jcm13061548

IF: 3.9

2024-03-09

Journal of Clinical Medicine

Abstract:Background: Thoracic aortic aneurysms (TAAs) associated with Marfan syndrome (MFS) are unique in that extracellular matrix metalloproteinase inducer (EMMPRIN) levels do not behave the way they do in other cardiovascular pathologies. EMMPRIN is shed into the circulation through the secretion of extracellular vesicles. This has been demonstrated to be dependent upon the Membrane Type-1 MMP (MT1-MMP). We investigated this relationship in MFS TAA tissue and plasma to discern why unique profiles may exist. Methods: Protein targets were measured in aortic tissue and plasma from MFS patients with TAAs and were compared to healthy controls. The abundance and location of MT1-MMP was modified in aortic fibroblasts and secreted EMMPRIN was measured in conditioned culture media. Results: EMMPRIN levels were elevated in MFS TAA tissue but reduced in plasma, compared to the controls. Tissue EMMPRIN elevation did not induce MMP-3, MMP-8, or TIMP-1 expression, while MT1-MMP and TIMP-2 were elevated. MMP-2 and MMP-9 were reduced in TAA tissue but increased in plasma. In aortic fibroblasts, EMMPRIN secretion required the internalization of MT1-MMP. Conclusions: In MFS, impaired EMMPRIN secretion likely contributes to higher tissue levels, influenced by MT1-MMP cellular localization. Low EMMPRIN levels, in conjunction with other MMP analytes, distinguished MFS TAAs from controls, suggesting diagnostic potential.

medicine, general & internal
Preoperative induction chemotherapy in the treatment of locally advanced soft tissue sarcomas

J. Rouëssé,S. Friedman,D. Sevin,T. le Chevalier,M. Spielmann,G. Contesso,D. Sarrazin,J. Génin

DOI: https://doi.org/10.1002/1097-0142(19870801)60:3<296::AID-CNCR2820600305>3.0.CO;2-D

IF: 6.9209

1987-08-01

Cancer

Abstract:Evidence that supports the use of systemic, presurgical induction chemotherapy to render soft tissue sarcomas resectable or to minimize the extent of surgical excision is presented. Induction chemotherapy was administered in 34 cases of nonmetastatic soft tissue sarcomas. All patients had large tumors for which only mutilating surgery, if any, was possible. In 21 patients, a combination of Adriamycin (doxorubicin), cyclophosphamide, cisplatin, vindesine, and DTIC (DCPAV) produced two complete remissions (CR) and 6 partial remissions (PR). A combination of cyclophosphamide, vincristine, Adriamycin, and DTIC (CYVADIC) produced three PR in eight patients, and a combination of Adriamycin and ifosfamide (AI) produced two PR in five patients. After two to seven cycles of chemotherapy, 24 patients underwent surgery. In 19, gross tumor excision was performed; 12 proved to be microscopically fully resected. Disease in two patients entered CR with chemotherapy alone, but surgery was performed in both patients as well. Irradiation was administered in ten patients to produce or insure CR (eight cases of residual disease postoperatively), and in two patients with unresectable disease. Four patients with disease in CR after surgery also received radiation due to the initial massive tumor size. The Kaplan‐Meier survival curves at 2 years showed 18% total survival in the patients in whom CR of disease was not achieved, and 80% survival in patients with disease in CR. Of the 22 patients with disease in CR (by all means), disease‐free survival was 1 to 44 months (mean, 13.7). Disease currently remains in CR in ten patients with a mean follow‐up of 13.6 months (3 to 34 months from end of therapy). Ten patients had a local recurrence following a CR after 3 to 44 months (mean, 15.3 months).
Systematical Analysis of Underlying Markers Associated with Marfan Syndrome Via Integrated Bioinformatics and Machine Learning Strategies

Guohua Wang,Chunjiang Liu,Qianyun Wu,Jiajia Wang,Xiaoqi Tang,Zhifeng Wu,Liming Tang,Yufei Zhou

DOI: https://doi.org/10.1080/07391102.2023.2233021

2024-01-01

Abstract:Marfan syndrome (MFS) is a hereditary disease with high mortality. This study aimed to explore peripheral blood potential markers and underlying mechanisms in MFS via a series bioinformatics and machine learning analysis. First, we downloaded two MFS datasets from the GEO database. A total of 215 differentially expressed genes (DEGs) and 78 differentially expressed miRNAs (DEMs) were identified via "Limma" package. 60 DEGs, mainly enriched in abnormal transportation of structure and energy substances, were selected after protein-protein interaction (PPI) network construction, of which 20 were chosen for machine learning after three algorithms (betweenness, closeness, and degree) filtration using Cytoscape. Four overlapping DEGs (ACTN1, CFTR, GCKR, LAMA3) were finally selected as the candidate markers based on three machine-learning approaches (Lasso, random forest, and support vector machine-recursive feature elimination). Furthermore, we collected peripheral blood from MFS patients and healthy control to validate the findings and the results showed that compared with the control, the expression of the four DEGs was all statistically different in MFS patients validated by qRT-PCR. Besides, the area under the receiver operating characteristics curve was greater than 0.8 for each DEG. Single-sample gene-set enrichment analysis showed that the four DEGs were strongly associated with inflammation and myogenesis pathway. Finally, we constructed the mRNA-miRNA network based on the intersection of DEMs and predicted miRNAs targeting DEGs. In conclusion, our study partially provided four potential markers for MFS pathogenesis.Communicated by Ramaswamy H. Sarma
Investigation of cardiovascular risk parameters in adolescents with metabolic syndrome

Ummugulsum Can,Sadinaz Akdu,Zafer Bağcı,Muammer Buyukinan

DOI: https://doi.org/10.1017/S1047951123001622

Abstract:Background: Metabolic syndrome leading to type 2 diabetes mellitus and cardiovascular diseases is a chronic multifactorial syndrome, associated with low-grade inflammation status. In our study, we aimed at assessing the serum levels of follistatin (FST), pregnancy-associated plasma protein-A (PAPP-A), and platelet/endothelial cell adhesion molecule-1 (PECAM-1) in adolescent patients with metabolic syndrome. Methods: This study was performed in 43 (19 males, 24 females) metabolic syndrome adolescents and 37 lean controls matched for age and sex. The serum levels of FST, PECAM-1, and PAPP-A were measured by using ELISA method. Results: Serum FST and PAPP-A levels in metabolic syndrome were significantly higher than those of controls (p < 0.005 and p < 0.05). However, there was no difference in serum PECAM-1 levels between metabolic syndrome and control groups (p = 0.927). There was a significant positive correlation between serum FST and triglyceride (r = 0.252; p < 0.05), and PAPP-A and weight, (r = 0.252; p < 0.05) in metabolic syndrome groups. Follistatin was determined statistically significant in both univariate (p = 0,008) and multivariate (p = 0,011) logistic regression analysis. Conclusions: Our findings indicated a significant relationship between FST and PAPP-A levels and metabolic syndrome. These findings offer the possibility of using these markers in diagnosis of metabolic syndrome in adolescents as the prevention of the future complications.
Correlation between interleukin-6 promoter and C-reactive protein (CRP) polymorphisms and CRP levels with the Mainz Severity Score Index for Fabry disease

G. Altarescu,G. Chicco,C. Whybra,S. Delgado‐Sanchez,N. Sharon,M. Beck,D. Elstein,S. Delgado-Sanchez

DOI: https://doi.org/10.1007/s10545-007-0716-6

IF: 4.7501

2008-01-05

Journal of Inherited Metabolic Disease

Abstract:OBJECTIVES: Fabry disease is a multisystem disorder with phenotypic heterogeneity only partially explained by genotype. Elevated interleukin-6 (IL-6) plasma levels and C-reactive protein (CRP) serum levels are associated with increased risk and worse outcome of ischaemic events, a serious prognostic sign in Fabry disease.METHODS: 56 patients (34 hemizygous males, 22 females; 5 children) were studied. A promoter polymorphism -174G > C of the IL-6 gene associated with serum IL-6 levels was compared with the Mainz Severity Score Index (MSSI) in patients with Fabry disease. CRP levels and polymorphism 1059 G > C were evaluated as markers of inflammation to ascertain the possibility of an inflammatory mechanism of IL-6. Nonparametric ANOVA, Fisher's exact, Bonferroni, and Hardy-Weinberg (HW) statistics were used.RESULTS: Mean age of adults = 42 (range 26-58) years; 29 patients received enzyme therapy (ERT). Mean total MSSI = 26.7 (range 14.2-39.2) points, i.e. moderate disease, but females were lower (total 23.4 +/- 12.6 vs 32.2 +/- 13.6). Controls but not patients were in HW equilibrium. Significant correlation existed between all sub-scores of the MSSI and IL-6 genotypes in females but only with three MSSI sub-scores for males. The IL-6 C/C genotype was significantly correlated with the neurological, general and total MSSI sub-scores, generally twofold higher. There were no statistically significant correlations with CRP levels/polymorphisms and MSSI sub-scores nor with IL-6 polymorphisms. CRP levels decreased after ERT in patients with IL-6 G/G or G/C genotypes but increased in patients with C/C (p = 0.003).CONCLUSIONS: The prevalence of the IL-6 C allele significantly influences MSSI, i.e. clinical severity, especially in females. This is unrelated to IL-6 as a pro-inflammatory marker as demonstrated by lack of correlations with CRP levels and genotypes. IL-6 -174 polymorphic C allele may be a prognostic marker in Fabry disease, especially in females.

genetics & heredity,endocrinology & metabolism,medicine, research & experimental
Correlation of Matrix Metalloproteinase-2 Single Nucleotide Polymorphisms with the Risk of Small Vessel Disease (SVD)

Min Zhang,Wusheng Zhu,Wenwei Yun,Qizhang Wang,Maogang Cheng,Zhizhong Zhang,Xinfeng Liu,Xianju Zhou,Gelin Xu

DOI: https://doi.org/10.1016/j.jns.2015.04.056

IF: 4.4

2015-01-01

Journal of the Neurological Sciences

Abstract:Background: Maladjustment of matrix metalloproteinases (MMPs) results in cerebral vasculature and blood-brain barrier dysfunction, which is associated with small vessel disease (SVD). This study was to aim at evaluating correlations between matrix metalloproteinase-2 and 9 single nucleotide polymorphisms and the risk of SVD.Methods: A total of 178 patients with SVD were enrolled into this study via Nanjing Stroke Registry Program (NSRP) from January 2010 to November 2011. SVD patients were further subtyped as isolated lacunar infarction (ILI, absent or with mild leukoaraiosis) and ischemic leukoaraiosis (ILA, with moderate or severe leukoaraiosis) according to the Fazekas scale. 100 age- and gender-matched individuals from outpatient medical examination were recruited as the control group. The genotypes of MMP-2-1306 T/C and MMP-9-1562 cir were determined by the TagMan method. Results: Of 178 SVD patients, 86 and 92 patients were classified as ILI and ILA, respectively. Comparison analysis between SVD patients and controls revealed a significant correlation between SVD and hypertension, as well as a prevalence of hypertension in ILA. Further genotype analysis showed that the frequency of MMP-2-1306 CC genotype was higher in ILA patients than in controls (P = 0.009, chi(2) test; P = 0.027, the multiple test with Bonferroni correction). Finally, logistic regression analysis with adjustment of age, sex and vascular risk factors showed that the MMP-2-1306 T/C polymorphism was an independent predictor for ILA (OR: 2.605; 95% confidence interval [CI], 1.067-6.364; P = 0.036).Conclusion: Our findings suggest that the MMP-2-1306 T/C polymorphism is a direct risk factor for ILA. (C) 2015 Published by Elsevier B.V.
Characteristics of arthritis in patients with familial Mediterranean fever

Selcan Yenigun,Ali Yagiz Ayla,Mebrure B. Yuzbasioglu,Sura N. Baspinar,Sercan Ergun,Ali Karabicek,Cagri Belli,Fatma Demirkol,Huri Ozdogan,Serdal Ugurlu

DOI: https://doi.org/10.1111/imj.16495

2024-08-24

Internal Medicine Journal

Abstract:Background Many of the familial Mediterranean fever (FMF) patients present with arthritis during attacks, which may vary in its characteristics. Aims In this study, we aimed to describe and characterise arthritis in FMF patients. Methods We used our hospital's record system to retrospectively identify FMF patients with arthritis who presented to our clinic between 2005 and 2020. The prevalence, laboratory results of attack, remission periods, genetic mutations, demographic data, characteristics of attacks, characteristics of arthritis, comorbidities, treatments and treatment responses were recorded. Results Nine hundred fifty‐four patients from a cohort of 2350 FMF patients had arthritis (40%). The male/female ratio was 0.49 in patients with arthritis. The frequency of at least one exon 10 mutation was high. The age of onset of symptoms was earlier for patients with arthritis. Monoarticular pattern was more frequent compared to oligo‐ and polyarticular patterns. Colchicine resistance was higher; the required colchicine dose for disease control and the frequency of use of biological agents were higher compared to general FMF population. Conclusion Since M694V mutation is common and the colchicine dose required for disease control is high, we can conclude that the disease activity is high in FMF patients with arthritis. The frequency of sacroiliitis and spondyloarthropathy is significantly increased, especially in individuals with M694V mutation, suggesting that there may be a common pathway in their pathogenesis. FMF should be included in the differential diagnosis in patients presenting with arthritis in FMF endemic regions.

medicine, general & internal
Ocular blood flow and retinal, choroidal, and retinal nerve fiber layer thickness in children with familial Mediterranean fever with at least five attacks

Mehmet Tahir Eski,Mehtap Oktay

DOI: https://doi.org/10.1007/s10792-022-02310-9

IF: 2.029

2022-05-06

International Ophthalmology

Abstract:Purpose This study aimed to evaluate ocular blood flow and, retinal, choroidal and retinal nerve fiber layer thickness in children with familial Mediterranean fever (FMF) with patients who had at least five attacks. Methods Fifty-six patients with FMF and 56 healthy subjects were enrolled in the study. Each participant's choroidal thickness (CT) and retinal thickness (RT) measurements were performed in the foveola and at horizontal nasal and temporal quadrants within 500-μm intervals up to 1.500 μm from the foveola using spectral-domain optical coherence tomography as well as the retinal nerve fiber layer thickness (RNFLT). Disc boundaries were determined manually by identifying seven points on the inner edge of the scleral ring. Following complete ophthalmological evaluation, peak systolic velocity (PSV), end-diastolic velocity (EDV), and resistivity index (RI) values in the central retinal artery (CRA), ophthalmic artery (OA), and nasal posterior ciliary artery (NPCA) were measured using color Doppler ultrasonography (CDU) in the left eyes of the patients diagnosed with FMF and the controls. The results were subsequently compared. Results No statistically significant differences were observed between the groups in terms of all RNFLT quadrant and RT measurements. All CT measurements were thinner in patients with FMF than in the controls (For Central and Temporal_1500 p = 0.01; For Temporal_500, Nasal 500 and Nasal_1000 p < 0.001; Temporal_1000 p = 0.002) except than the Nasal_1500 point. For nasal_1500 p = 0.121). The PSV and EDV values in the OA, CRA, and NPCA were significantly lower in patients with FMF compared to healthy controls ( p < 0.001 for all). In contrast, the RI values of all arteries were significantly higher than in the control group (Regarding OA, CRA and NPCA RI, p = 0.003, p = 0.039, and p = 0.039, respectively). Conclusions The results of this study support the idea that chronic inflammation and frequent attacks in FMF may have an effect on decreased ocular blood flow and choroidal thinning.

ophthalmology
Assessment of the Level of Matrix Metalloproteinases, VEGF and MicroRNA-34a in Patients With Non-obstructive and Obstructive Lesions of the Coronary Arteries

A O Iusupova,O A Slepova,N N Pakhtusov,L V Popova,A A Ageev,A S Lishuta,E V Privalova,N V Khabarova,G М Dadashovа,Yu N Belenkov

DOI: https://doi.org/10.18087/cardio.2024.4.n2622

2024-04-30

Kardiologiia

Abstract:Aim: To assess the levels of matrix metalloproteinases (MMP), vascular endothelial growth factor (VEGF), and miRNA-34a expression in patients with ischemic heart disease (IHD) and obstructive and nonobstructive coronary artery (CA) disease. Material and methods: This cross-sectional observational study included 64 patients with IHD (diagnosis verified by coronary angiography or multislice computed tomography coronary angiography), of which 33 (51.6%) were men aged 64.9±8.1 years. 20 patients had nonobstructive CA disease (stenosis <50%), and 44 had hemodynamically significant stenoses. The control group consisted of 30 healthy volunteers. MMP-1, -9, -13, and -14, miRNA-34a, and VEGF were measured in all patients. Results: The concentration of MMP-1 was significantly higher in patients with ischemia and nonobstructive CA disease (INOCAD) (p=0.016), and the concentration of MMP-9 was the highest in the group with obstructive CA disease (p<0.001). The concentrations of MMP-13 and MMP-14 did not differ significantly between the groups. The highest VEGF concentrations were observed in the INOCAD group (p<0.001). The expression of miRNA-34a significantly differed between the IHD groups with different types of CA disease and controls (p <0.001). Patients with hemodynamically significant stenosis showed moderate relationships between the concentrations of MMP-14 and VEGF (ρ=0.418; p=0.024), as well as between VEGF and miRNA-34a (ρ=0.425; p=0.022). Patients with INOCAD had a significant negative correlation between the concentrations of MMP-13 and VEGF (ρ= -0.659; p=0.003). Correlation analysis showed in all IHD patients a moderate relationship of the concentrations of MMP-1 and MMP-14 with VEGF (ρ=0.449; p=0.002 and p=0.341; p=0.019, respectively). According to ROC analysis, a MMP-9 concentration above 4.83 ng/ml can be a predictor for the presence of hemodynamically significant CA obstruction in IHD patients; a VEGF concentration higher than 27.23 pg/ml suggests the absence of hemodynamically significant CA stenosis. Conclusion: IHD patients with INOCAD had the greatest increase in MMP-1, whereas patients with obstructive CA disease had the highest level of MMP-9. According to our data, concentrations of MMP-9 and VEGF can be used to predict the degree of CA obstruction. The expression of miRNA-34a was significantly higher in IHD patients with INOCAD and CA obstruction than in the control group, which suggested a miRNA-34a contribution to the development and progression of coronary atherosclerosis. In the future, it may be possible to use this miRNA as a diagnostic marker for IHD.

PReS-FINAL-2205: Vascular risk assesment and MMP-3 gene in FMF

Assessment of epicardial adipose tissue thickness and the mean platelet volume in children with familial Mediterranean fever

α9β1 integrin & its ligands as new potential biomarkers in FMF

Exploring S100A8/A9, neopterin, and MMP3 in familial Mediterranean fever

Clinical Implications of Three-Vessel Fractional Flow Reserve Measurement in Patients with Coronary Artery Disease

Pan-Immune-Inflammation Value Could Be a New Marker to Predict Amyloidosis and Disease Severity in Familial Mediterranean Fever

Association of MMP9 with adverse features of plaque progression and residual inflammatory risk in patients with chronic coronary syndrome (CCS)

Risk for cancer development in familial Mediterranean fever and associated predisposing factors: an ambidirectional cohort study from the international AIDA Network registries

Identification of a functional missense variant in the matrix metallopeptidase 10 (MMP10) gene in two families with premature myocardial infarction

(O-12) Modulation Of Mmp Expression And Collagen Deposition In The Tunica Albuginea In Peyronie ́S Disease Induced After Treatment With Mycophenolate Mofetil

A Marfan syndrome gene expression phenotype in cultured skin fibroblasts

Serum endocan, asymmetric dimethylarginine and lipid profile in children with familial Mediterranean fever

EMMPRIN Tissue and Plasma Levels in Marfan Syndrome-Related Thoracic Aortic Aneurysms

Preoperative induction chemotherapy in the treatment of locally advanced soft tissue sarcomas

Systematical Analysis of Underlying Markers Associated with Marfan Syndrome Via Integrated Bioinformatics and Machine Learning Strategies

Investigation of cardiovascular risk parameters in adolescents with metabolic syndrome

Correlation between interleukin-6 promoter and C-reactive protein (CRP) polymorphisms and CRP levels with the Mainz Severity Score Index for Fabry disease

Correlation of Matrix Metalloproteinase-2 Single Nucleotide Polymorphisms with the Risk of Small Vessel Disease (SVD)

Characteristics of arthritis in patients with familial Mediterranean fever

Ocular blood flow and retinal, choroidal, and retinal nerve fiber layer thickness in children with familial Mediterranean fever with at least five attacks

Assessment of the Level of Matrix Metalloproteinases, VEGF and MicroRNA-34a in Patients With Non-obstructive and Obstructive Lesions of the Coronary Arteries